Wayfinding Financial, LLC Merck & Co., Inc. Transaction History

Wayfinding Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $143,112 - $153,701	-1,156 Reduced 21.73%	4,163 $515,000
Q1 2024 May 09, 2024	BUY	$113.24 - $131.95 $49,259 - $57,398	435 Added 8.91%	5,319 $701,000
Q4 2023 Jan 09, 2024	SELL	$100.18 - $109.02 $29,452 - $32,051	-294 Reduced 5.68%	4,884 $536,000
Q3 2023 Nov 02, 2023	SELL	$102.95 - $114.33 $24,605 - $27,324	-239 Reduced 4.41%	5,178 $533,000
Q2 2023 Jul 31, 2023	BUY	$108.61 - $118.38 $38,773 - $42,261	357 Added 7.06%	5,417 $625,000
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $39,528 - $44,106	384 Added 8.21%	5,060 $538,000
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $23,871 - $30,606	-273 Reduced 5.52%	4,676 $376,000
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $7,185 - $8,071	85 Added 1.75%	4,949 $429,000
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $1,586 - $1,798	19 Added 0.39%	4,864 $446,000
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $12,423 - $13,925	169 Added 3.61%	4,845 $428,000
Q4 2021 Jan 28, 2022	BUY	$72.28 - $90.54 $337,981 - $423,365	4,676 New	4,676 $376,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Wayfinding Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Wayfinding Financial, LLC with notifications on news.